Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article matching "Pemphigus vulgaris"

ResearchCLINICALTRIALSMar 26

Trial Completed: Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists (NCT07428915)

Researchers completed a study testing whether an AI tool called Legit.Health Plus can help doctors better diagnose rare and complicated skin conditions. The tool was tested with 15 healthcare providers to see if it could reduce the gap between what general doctors and skin specialists diagnose. This matters because conditions like Generalized Pustular Psoriasis and Hidradenitis Suppurativa can be missed or misdiagnosed, delaying proper treatment.

WHY IT MATTERSThis completed trial tested an AI diagnostic tool specifically designed to help primary care doctors accurately identify rare skin conditions like Generalized Pustular Psoriasis and Hidradenitis Suppurativa, which are often missed in non-specialist settings.
Good to knowGeneralized Pustular PsoriasisPustular PsoriasisHidradenitis SuppurativaRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases